Summary and Perspective

摘要: The earlier chapters of this volume have attempted to identify potential new target molecules that may represent useful cancer markers and provided information regarding their biological function as well the or actual clinical utilization extent such is known. These candidate tumor reflect alterations in antigenic composition gene expression structure. A listing some genetic judged be most promising presented Table 1. Which these will ultimately incorporated into practice unknown. Selection more effective lead improvement quality patient care, whereas selection ineffective inflate health care costs without perceived benefit. latter serve cast added doubt on usefulness for supporting development future.